Strategic Initiative

Slingshot members are tracking this corporate initiative:

Jazz Pharmaceuticals (JAZZ) Acquires SpringWorks Therapeutics' (SWTX) FAAH Inhibitor Program for post-traumatic stress disorder

Source Link:
https://investor.jazzpharma.com/news-releases/news-release-details/jazz-pharmaceuticals-acquires-springworks-therapeutics-faah

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
JAZZ
100%
SWTX
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Jazz to Make Upfront Payment of $35 Million to SpringWorks with Potential Milestone Payments of Up to $375 Million
https://investor.jaz...
Slingshot Insights Explained
JOIN FOR FREE TODAY
Strategic Initiative Date
Announcement Date:
Oct 26, 2020
Projected Implementation:
Q4, 2020
Relevance Tracked Until:
Q1, 2021
Related Projects Image

  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Faah Inhibitor, Fatty Acid Amide Hydrolase, Post-traumatic Stress Disorder, Ptsd
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.